Chemoinformaics analysis of 19-Acetylgnaphalin(terpene)
| Molecular Weight | 402.443 | nRot | 3 |
| Heavy Atom Molecular Weight | 376.235 | nRig | 27 |
| Exact Molecular Weight | 402.168 | nRing | 5 |
| Solubility: LogS | -4.268 | nHRing | 3 |
| Solubility: LogP | 1.898 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 5 |
| nHA | 7 | APOL | 59.6906 |
| nHD | 0 | BPOL | 35.6314 |
| QED | 0.566 |
| Synth | 5.579 |
| Natural Product Likeliness | 3.025 |
| NR-PPAR-gamma | 0.594 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.552 |
| Pgp-sub | 0.063 |
| HIA | 0.004 |
| CACO-2 | -5.173 |
| MDCK | 0.00002 |
| BBB | 0.949 |
| PPB | 0.770719 |
| VDSS | 1.312 |
| FU | 0.217008 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.868 |
| CYP2c19-inh | 0.79 |
| CYP2c19-sub | 0.59 |
| CYP2c9-inh | 0.439 |
| CYP2c9-sub | 0.05 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.121 |
| CYP3a4-inh | 0.721 |
| CYP3a4-sub | 0.686 |
| CL | 8.187 |
| T12 | 0.514 |
| hERG | 0.023 |
| Ames | 0.801 |
| ROA | 0.983 |
| SkinSen | 0.126 |
| Carcinogencity | 0.898 |
| EI | 0.212 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.819 |
| Antiviral | Yes |
| Prediction | 0.616635 |